Enanta Pharmaceuticals
ENTA
ENTA
131 hedge funds and large institutions have $621M invested in Enanta Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 27 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 117 → 131 (+14)
11% more call options, than puts
Call options by funds: $1.55M | Put options by funds: $1.39M
Holders
131
Holding in Top 10
4
Calls
$1.55M
Puts
$1.39M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$12.7M | |
| 3 | +$11.9M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$10.6M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$10.6M |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$14M | |
| 3 | -$8.17M | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$4.72M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.55M |